ClinicalTrials.Veeva

Menu

Psychotherapy Trial With Transgender Clients

University of Wisconsin (UW) logo

University of Wisconsin (UW)

Status

Completed

Conditions

Transgender Persons, M01.777.500

Treatments

Behavioral: Treatment As usual
Behavioral: Minority Stress Treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT03369054
2017-0816
A171600 (Other Identifier)
EDUC\COUNSELING PSYCH (Other Identifier)

Details and patient eligibility

About

Transgender and gender diverse (TGD) individuals are at an increased risk for mental health concerns, including anxiety, trauma-based distress, depression, self-harm, and suicidality. Quantitative and qualitative studies have shown that support appears to mediate mental health concerns, but to date, there have been zero psychotherapy studies focusing on transgender and gender diverse patients. The NIH has noted that TGD patients are considered to be a "health disparities population," indicating that there is considerable research to support prevention and reduction in mental health disparities for this population.

There are two aims to the current study-Aim 1: investigate the feasibility of conducting a psychotherapy randomized controlled trial for transgender and gender diverse populations, and Aim 2: longitudinally investigate the impact of minority stress interventions on well-being for transgender and gender diverse patients.

First, it is hypothesized that this study will demonstrate feasibility regarding recruitment of transgender and gender diverse patients and that patients from both groups will report treatment acceptability. We also hypothesize that patients will report more acceptability for treatments that are focused on minority stress interventions. It is hypothesized that individuals in both the Minority Stress Treatment (MST) group and Treatment as Usual (TAU) group will both show improvements in well-being, but that the MST group will demonstrate larger effects in outcomes.

No known published studies have focused on minority stress psychotherapy interventions for transgender and gender diverse populations. The findings from the proposed study will provide a multitude of information regarding longitudinal psychotherapy interventions focusing on minority stress that will inform future treatment manuals and larger, multi-site studies.

Enrollment

20 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age of 18 or older
  • Fluent in written and spoken English
  • Willingness to participate in pre/post/session-by-session assessments and 12 ----Individual psychotherapy treatment sessions
  • Individual identifies as transgender, trans, or non-binary (or somewhere along the gender minority spectrum).

Exclusion criteria

  • Under 18 years old
  • Reports current, unmanaged psychotic symptoms or symptoms requiring immediate inpatient treatment (e.g., hallucinations, delusions, threatening immediate suicidal behaviors)
  • Currently engaging in psychotherapy
  • Cannot attend therapy on Tuesdays from 2-7pm
  • Individuals who lack the capacity to provide consent will be excluded.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

20 participants in 2 patient groups

Minority Stress
Experimental group
Description:
The (MST) condition will include a psychoeducation session on minority stress for all participants during the initial assessment session prior to their first psychotherapy session. Prior to attending each of the 12 psychotherapy sessions during their electronic assessment (filling out the OQ-45 on Qualtrics on a computer provided by the study team), patients will be prompted to report up to three minority stress experiences over the previous week in the survey tool (which the therapists will not see). They will be prompted by their therapist to discuss these experiences within their psychotherapy sessions (for example, "Would you like to discuss any of the minority stress experiences you've had over the week?").
Treatment:
Behavioral: Minority Stress Treatment
Treatment as Usual
Active Comparator group
Description:
Treatment-as-usual (TAU) will occur as any usual 12-week treatment. The therapists will be encouraged to discuss any of the presenting concerns reported by patients and supervision will include usual care.
Treatment:
Behavioral: Treatment As usual

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems